The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Fluorine in medicinal chemistry: A review of anti-cancer agents
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fluorinated pyrimidines, a new class of tumour-inhibitory compounds
HEIDELBERGER, C., CHAUDHURI, N. K., DANNEBERG, P., MOOREN, D., GRIESBACH, L., DUSCHINSKY, R., SCHNITZER, R. J., PLEVEN, E., & SCHEINER, J. (1957) · Nature · doi:10.1038/179663a0 · Cited by 1,603
Fluorine in Medicinal Chemistry
Böhm, H., Banner, D., Bendels, S., Kansy, M., Kuhn, B., Müller, K., Obst‐Sander, U., & Stahl, M. (2004) · ChemBioChem · doi:10.1002/cbic.200301023 · Cited by 1,572
Review of epidermal growth factor receptor biology
Herbst, R. S. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.11.041 · Cited by 1,390
Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery
Nussmeier, N. A., Whelton, A. A., Brown, M. T., Langford, R. M., Hoeft, A., Parlow, J. L., Boyce, S. W., & Verburg, K. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050330 · Cited by 1,092
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
Sebolt-Leopold, J. S., Dudley, D. T., Herrera, R., Becelaere, K. V., Wiland, A., Gowan, R. C., Tecle, H., Barrett, S. D., Bridges, A., Przybranowski, S., et al. (1999) · Nature Medicine · doi:10.1038/10533 · Cited by 970
Modern Fluoroorganic Chemistry: Synthesis, Reactivity, Applications
Kirsch, P. (2004) · Cited by 700
Cyclooxygenase-2: A Therapeutic Target
Turini, M. E., & DuBois, R. N. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103952 · Cited by 683
Cyclooxygenase inhibitors – current status and future prospects
Dannhardt, G., & Kiefer, W. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01197-7 · Cited by 657
Barker, A. J., Gibson, K. H., Grundy, W., Godfrey, A. A., Barlow, J. J., Healy, M. P., Woodburn, J. R., Ashton, S. E., Curry, B. J., Scarlett, L., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00344-4 · Cited by 569
Avril, N., Rosé, C. A., Schelling, M., Dose, J., Kuhn, W., Bense, S., Weber, W., Ziegler, S., Graeff, H., & Schwaiger, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.20.3495 · Cited by 557
Research works printed but not linked: 67
- Danenberg, 2004, Frontiers Biosci., 9, 2484, 10.2741/1410 · doi:10.2741/1410
- Peters, 2002, Biochem. Biophys. Acta, 1587, 194
- Punt, 1998, Cancer, 83, 679, 10.1002/(SICI)1097-0142(19980815)83:4<679::AID-CNCR8>3.0.CO;2-F · doi:10.1002/(sici)1097-0142(19980815)83:4<679::aid-cncr8>3.0.co;2-f
- Petty, 2004, Curr. Cancer Drug Targets, 4, 191, 10.2174/1568009043481533 · doi:10.2174/1568009043481533
- Feliu, 2004, Br. J. Cancer, 91, 1758, 10.1038/sj.bjc.6602217 · doi:10.1038/sj.bjc.6602217
- Shirasaka, 1996, Cancer Res., 56, 2602
- Xu, 2001, Clin. Cancer Res., 7, 3314
- Cooke, 2001, Org. Process. Res. Dev., 5, 383, 10.1021/op0100100 · DOI
- Kalman, 2000, Biorg. Med. Chem. Lett., 10, 391, 10.1016/S0960-894X(00)00012-3 · doi:10.1016/s0960-894x(00)00012-3
- Kalman, 2001, Nucleosides Nucleotides, 20, 869, 10.1081/NCN-100002448 · doi:10.1081/ncn-100002448
- Tanabe, 2005, Biorg. Med. Chem. Lett., 15, 2321, 10.1016/j.bmcl.2005.03.013 · doi:10.1016/j.bmcl.2005.03.013
- Herrlinger, 2005, Pharm. Genomics, 15, 2005
- Jackman, 2002, Biochim. Biophys. Acta, 1587, 215, 10.1016/S0925-4439(02)00084-4 · doi:10.1016/s0925-4439(02)00084-4
- Foss, 2004, Best Pract. Res. Clin. Hematol., 17, 573, 10.1016/S1521-6926(04)00075-1 · doi:10.1016/s1521-6926(04)00075-1
- Cataland, 2001, Curr. Pharm. Biotechnol., 2, 357, 10.2174/1389201013378608 · doi:10.2174/1389201013378608
- Brackwitz, 1999, Biorg. Chem. Med. Lett., 7, 1195, 10.1016/S0968-0896(99)00027-9 · doi:10.1016/s0968-0896(99)00027-9
- Bauta, 2004, Org. Process. Res. Dev., 8, 889, 10.1021/op049884n · doi:10.1021/op049884n
- Pourquier, 2002, Clin. Cancer Res., 8, 2499
- Jiang, 2000, Cancer Chem. Pharm., 45, 320, 10.1007/s002800050047 · doi:10.1007/s002800050047
- Walkins, 2005, Curr. Pharm. Des., 11, 1615, 10.2174/1381612053764742 · doi:10.2174/1381612053764742
- Nicolaou, 1998, Angew. Chem. Int. Ed., 37, 1418, 10.1002/(SICI)1521-3773(19980605)37:10<1418::AID-ANIE1418>3.0.CO;2-5 · doi:10.1002/(sici)1521-3773(19980605)37:10<1418::aid-anie1418>3.0.co;2-5
- Honore, 2003, Mol. Cancer Ther., 2, 1303
- Mooberry, 1999, Cancer Res., 59, 653
- Hood, 2002, Cancer Res., 62, 3356
- Gao, 2005, Biorg. Med. Chem. Lett., 15, 3233, 10.1016/j.bmcl.2005.04.063 · doi:10.1016/j.bmcl.2005.04.063
- Zunino, 1990, Anticancer Drug Des., 5, 307
- Giannini, 2004, Med. Chem. Rev., 1, 47
- Xia, 2001, J. Med. Chem., 44, 3932, 10.1021/jm0101085 · doi:10.1021/jm0101085
- Rubin, 2002, Clin. Cancer Res., 8, 3710
- Stüdemann, 1997, Tetrahedron, 54, 1229
- Stüdemann, 1997, Angew. Chem. Int. Ed. Engl., 36, 93, 10.1002/anie.199700931 · doi:10.1002/anie.199700931
- Pasqualini, 2004, Biochimica Biophys. Acta, 1654, 123
- Konno, 2004, Org. Lett., 6, 933, 10.1021/ol036440n · doi:10.1021/ol036440n
- Robertson, 2005, Eur. J. Cancer, 41, 346, 10.1016/j.ejca.2004.07.035 · doi:10.1016/j.ejca.2004.07.035
- Howell, 2004, Eur. J. Cancer, 9, 65
- Dodwell, 2005, Cancer Treatment Rev., 31, 274, 10.1016/j.ctrv.2005.03.009 · doi:10.1016/j.ctrv.2005.03.009
- de Velde, 1995, Ann. N.Y. Acad. Sci., 761, 164, 10.1111/j.1749-6632.1995.tb31377.x · doi:10.1111/j.1749-6632.1995.tb31377.x
- Jordan, 2003, J. Med. Chem., 46, 893
- Giannoukos, 2001, Mol. Endocrinol., 15, 255, 10.1210/me.15.2.255 · doi:10.1210/me.15.2.255
- Cleve, 2005, J. Fluorine Chem., 126, 217, 10.1016/j.jfluchem.2004.08.004 · doi:10.1016/j.jfluchem.2004.08.004
- Noble, 2004, Drug Discov., 303, 1800
- Matushansky, 2005, Am. Scientist, 93, 414, 10.1511/2005.55.972 · doi:10.1511/2005.55.972
- Alberti, 2005, Birog. Med. Chem. Lett., 15, 3778, 10.1016/j.bmcl.2005.05.100 · DOI
- Cockerill, 2002, Curr. Top. Med. Chem., 2, 1001, 10.2174/1568026023393309 · doi:10.2174/1568026023393309
- Herbst, 2004, Int. J. Radiat. Oncol. Biol. Phys., 59, 21, 10.1016/j.ijrobp.2003.10.027 · doi:10.1016/j.ijrobp.2003.10.027
- Pandey, 2003, World J. Surg. Oncol., 1, 9, 10.1186/1477-7819-1-9 · doi:10.1186/1477-7819-1-9
- Bell, 2004, J. Med. Chem., 47, 1869, 10.1021/jm0305467 · doi:10.1021/jm0305467
- Piatnitski, 2005, Biorg. Med. Chem. Lett., 15, 4696, 10.1016/j.bmcl.2005.07.064 · doi:10.1016/j.bmcl.2005.07.064
- Gingrich, 2003, J. Med. Chem., 46, 5375, 10.1021/jm0301641 · doi:10.1021/jm0301641
- Fink, 2005, Biorg. Med. Chem., 15, 4774, 10.1016/j.bmcl.2005.07.027 · doi:10.1016/j.bmcl.2005.07.027
- Ahn, 2005, Science, 308, 1266, 10.1126/science.1113707 · doi:10.1126/science.1113707
- Nair, 2004, Tetrahedron Lett., 45, 9475, 10.1016/j.tetlet.2004.10.130 · doi:10.1016/j.tetlet.2004.10.130
- Sani, 2005, Lett. Org. Chem., 2, 447, 10.2174/1570178054405850 · doi:10.2174/1570178054405850
- Barker, 2005, J. Med. Chem., 48, 4507, 10.1021/jm050345y · doi:10.1021/jm050345y
- Kankaaranta, 1995, Mol. Pharmacol., 47, 1006
- Armer, 2005, J. Med. Chem., 48, 6174, 10.1021/jm050519b · doi:10.1021/jm050519b
- Goldman, 2002, Formulary, 37, 68
- Schedler, 2004, Carbohydr. Res., 339, 1585, 10.1016/j.carres.2004.03.030 · doi:10.1016/j.carres.2004.03.030
- El-Kabbani, 2005, J. Med. Chem., 48, 5536, 10.1021/jm050412o · DOI
- Whitehead, 2005, J. Med. Chem., 48, 1237, 10.1021/jm030603w · doi:10.1021/jm030603w
- Guo, 2005, Biorg. Med. Chem. Lett., 15, 3685, 10.1016/j.bmcl.2005.05.038 · doi:10.1016/j.bmcl.2005.05.038
- Gründker, 2000, Gynecol. Oncol., 78, 194, 10.1006/gyno.2000.5863 · doi:10.1006/gyno.2000.5863
- Kunkel, 2003, Cancer, 98, 2257, 10.1002/cncr.11763 · doi:10.1002/cncr.11763
- Toyokuni, 2005, Biorg. Med. Chem. Lett., 15, 4699, 10.1016/j.bmcl.2005.07.065 · doi:10.1016/j.bmcl.2005.07.065
- Wang, 2005, Biorg. Med. Chem. Lett., 15, 4380, 10.1016/j.bmcl.2005.06.038 · doi:10.1016/j.bmcl.2005.06.038
- Cui, 2004, Magn. Resonance Med., 51, 616, 10.1002/mrm.10719 · doi:10.1002/mrm.10719
- Yu, 2004, Bioconjug. Chem., 15, 1334, 10.1021/bc049936d · doi:10.1021/bc049936d
Cited by
Fluorine in Pharmaceuticals: Looking Beyond Intuition
Müller, K., Faeh, C., & Diederich, F. (2007) · Science · doi:10.1126/science.1131943 · Cited by 6,596
Wang, J., Sánchez-Roselló, M., Aceña, J. L., del Pozo, C., Sorochinsky, A. E., Fustero, S., Soloshonok, V. A., & Liu, H. (2014) · Chemical Reviews · doi:10.1021/cr4002879 · Cited by 4,847
Zhou, Y., Wang, J., Gu, Z., Wang, S., Zhu, W., Aceña, J. L., Soloshonok, V. A., Izawa, K., & Liu, H. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00392 · Cited by 2,808
Introduction of Fluorine and Fluorine‐Containing Functional Groups
Liang, T., Neumann, C. N., & Ritter, T. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201206566 · Cited by 2,564
Contribution of Organofluorine Compounds to Pharmaceuticals
Inoue, M., Sumii, Y., & Shibata, N. (2020) · ACS Omega · doi:10.1021/acsomega.0c00830 · Cited by 1,944
Fluorine in Medicinal Chemistry and Chemical Biology
(2009) · Wiley eBooks · doi:10.1002/9781444312096 · Cited by 1,731
Organic fluorine compounds: a great opportunity for enhanced materials properties
Berger, R., Resnati, G., Metrangolo, P., Weber, E., & Hulliger, J. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00221f · Cited by 1,514
Yang, X., Wu, T., Phipps, R. J., & Toste, F. D. (2015) · Chemical Reviews · doi:10.1021/cr500277b · Cited by 1,383
Fluorination in Medicinal Chemistry: Methods, Strategies, and Recent Developments
Kirk, K. L. (2008) · Organic Process Research & Development · doi:10.1021/op700134j · Cited by 1,151
Carbon Trifluoromethylation Reactions of Hydrocarbon Derivatives and Heteroarenes
Alonso, C., Martínez de Marigorta, E., Rubiales, G., & Palacios, F. (2015) · Chemical Reviews · doi:10.1021/cr500368h · Cited by 1,073
Monofluorination of Organic Compounds: 10 Years of Innovation
Champagne, P. A., Desroches, J., Hamel, J.-D., Vandamme, M., & Paquin, J.-F. (2015) · Chemical Reviews · doi:10.1021/cr500706a · Cited by 963
Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules
Kirk, K. L. (2006) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2006.06.007 · Cited by 900
Synthesis of 11C, 18F, 15O, and 13N Radiolabels for Positron Emission Tomography
Miller, P. W., Long, N. J., Vilar, R., & Gee, A. D. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800222 · Cited by 894
The role of fluorine in medicinal chemistry: Review Article
Shah, P., & Westwell, A. D. (2007) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360701425014 · Cited by 799
Recent advances (1995–2005) in fluorinated pharmaceuticals based on natural products
Bégué, J.-P., & Bonnet-Delpon, D. (2006) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2006.05.006 · Cited by 600
Direct Trifluoromethylthiolation Reactions: The “Renaissance” of an Old Concept
Toulgoat, F., Alazet, S., & Billard, T. (2014) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201301857 · Cited by 409
Fluorination methods in drug discovery
Yerien, D. E., Bonesi, S., & Postigo, A. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob00764c · Cited by 348
Filler, R., & Saha, R. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.65 · Cited by 338
Koller, R., Stanek, K., Stolz, D., Aardoom, R., Niedermann, K., & Togni, A. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900974 · Cited by 313
New Horizons of Photocatalytic Fluoromethylative Difunctionalization of Alkenes
Koike, T., & Akita, M. (2018) · Chem · doi:10.1016/j.chempr.2017.11.004 · Cited by 299
Direct C–F Bond Formation Using Photoredox Catalysis
Rueda-Becerril, M., Mahé, O., Drouin, M., Majewski, M. B., West, J. G., Wolf, M. O., Sammis, G. M., & Paquin, J.-F. (2014) · Journal of the American Chemical Society · doi:10.1021/ja412083f · Cited by 261
Willach, S., Brauch, H.-J., & Lange, F. T. (2016) · Chemosphere · doi:10.1016/j.chemosphere.2015.11.113 · Cited by 71
Metadata
- Authors
- Isanbor, C., & O’Hagan, D.
- Venue
- Journal of Fluorine Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 127
- Issue
- 3
- Pages
- 303-319
- ISSN
- 0022-1139 (ISSN-L)
- OpenAlex
- W2174657615
- Cited by
- 1,120
- References
- 104
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.